Two Sigma Advisers
NXTM

Two Sigma Advisers’s NxStage Medical Inc. NXTM Stock Holding History

Two Sigma Advisers’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-54,412
Closed -$1.32M – 2486
2017
Q4 		$1.32M Sell
54,412
-170,300
-76% -$4.49M ﹤0.01% 1422
2017
Q3 		$6.2M Sell
224,712
-37,329
-14% -$996K 0.02% 720
2017
Q2 		$6.57M Sell
262,041
-61,971
-19% -$1.53M 0.02% 654
2017
Q1 		$8.69M Buy
324,012
+95,725
+42% +$2.64M 0.03% 610
2016
Q4 		$5.98M Buy
228,287
+4,200
+2% +$104K 0.02% 659
2016
Q3 		$5.6M Sell
224,087
-28,300
-11% -$660K 0.02% 609
2016
Q2 		$5.47M Sell
252,387
-20,900
-8% -$373K 0.03% 526
2016
Q1 		$4.1M Buy
273,287
+3,866
+1% +$64.8K 0.02% 572
2015
Q4 		$5.9M Buy
269,421
+35,534
+15% +$662K 0.04% 409
2015
Q3 		$3.72M Buy
233,887
+17,899
+8% +$287K 0.02% 549
2015
Q2 		$3.08M Buy
215,988
+109,901
+104% +$1.86M 0.02% 641
2015
Q1 		$1.83M Buy
106,087
+86,600
+444% +$1.53M 0.01% 811
2014
Q4 		$349K Buy
+19,487
New +$314K ﹤0.01% 1855
2013
Q3 		– Sell
-34,987
Closed -$499K – 2513
2013
Q2 		$499K Buy
+34,987
New +$440K 0.01% 1326

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's NXTM Position: Q1 2018 in Review

Two Sigma Advisers sold out of NxStage Medical Inc. (NXTM) in Q1 2018, closing a stake of 54,412 shares — an estimated $1.32M sold.

Two Sigma Advisers first reported a position in NXTM in Q2 2013 and held it in 14 quarters. The position peaked at $8.69M in Q1 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q1 2018.

  • Two Sigma Advisers reported no remaining NxStage Medical Inc. position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Advisers sold 54,412 NxStage Medical Inc. shares in Q1 2018, an estimated $1.32M.
  • Two Sigma Advisers first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 14 quarters.
  • Two Sigma Advisers's NxStage Medical Inc. position peaked at $8.69M in Q1 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2018.

Based on Two Sigma Advisers's 13F filing for Q1 2018, filed 15 May 2018.